Start here

National Minority Health Month: Power to Prevent Diabetes

sb10063567al-001

April is National Minority Health Month
During National Minority Health Month, Ruby A. Neeson Diabetes Awareness Foundation, Inc., joins the HHS Office of Minority Health (OMH), and its partners in heightening public awareness about health care disparities that alarm minorities and efforts to progress endeavors to ensure that racial and ethnic minorities have full and equal access to opportunities that enable them to lead healthy lives.
The theme for National Minority Health Month 2015 is “30 Years of Advancing Health Equity | The Heckler Report: A Force for Ending Health Disparities in America.” This theme commemorates the U.S. Department of Health and Human Services (HHS) efforts towards eliminating health disparities among racial and ethnic minorities that were mobilized by the findings from the Report of the Secretary’s Task Force on Black and Minority Health, commonly referred to as the Heckler Report
Many racial and ethnic minority populations, including African Americans, Hispanics, American Indians, and Asian Americans are disproportionately affected by diabetes. Despite expedition towards eliminating health gaps, racial and ethnic minorities continue to face significant inequalities in the state of Georgia.
In an effort to reduce the unequal burden of health disparities, we are sharing seven important tips to help lower the risk for diabetes.

Seven Powerful Steps

MOVE MORE: Get up, get out, and get moving. Walk, dance, bike ride, swim, or play ball with your friends or family. It doesn’t matter what you do as long as you enjoy it. Try different things to keep it fun.
MAKE HEALTHY FOOD CHOICES: Focus on eating less. Eat fiber-rich fruits and vegetables each day. Choose whole grain foods such as whole wheat bread and crackers, oatmeal, brown rice, and cereals. Cut down on fatty and fried foods. You still can have foods you enjoy, just eat smaller servings. Choose water to drink.
TAKE OFF SOME WEIGHT: Once you start eating less and moving more, you will lose weight. By losing just 10 pounds, you can cut your chances of getting diabetes.
SET GOALS YOU CAN MEET: Start by making small changes. Try being active for 15 minutes a day this week. Then each week add 5 minutes until you build up to at least 30 minutes 5 days a week. Try to cut 150 calories out of your diet each day (that’s one can of soda!). Slowly reduce your calories over time. Talk to your health care team about your goals.
RECORD YOUR PROGRESS: Write down all the things you eat and drink and the number of minutes you are active. Keeping a diary is one of the best ways to stay focused and reach your goals.
SEEK HELP. You don’t have to prevent diabetes alone. Ask your family and friends to help you out. Involve them in your activities. You can help each other move more, eat less, and live a healthy life. Go for a walk together or play a pick-up game of basketball. Join a support group in your area to help you stay on track.
KEEP AT IT. Making even small changes is hard in the beginning. Try to add one new change a week. If you get off track, start again and keep at it.
Take your first step today. Talk to your healthcare team about your risk for type 2 diabetes and the small steps you can take to prevent it.

Ruby A. Neeson Diabetes Awareness Foundation, Inc. is a Georgia-based nonprofit charitable organization heightening diabetes awareness and prevention through education, community outreach programs, and advocacy support.

We are dedicated and committed to creating supportable, sustainable opportunities for those affected by diabetes.

For information on services and organization opportunities, please visit www.fightdiabetesnow.org.

Fight Diabetes Now- Together We Can Win!

Advertisements

Diabetes and Amputation: Protect Your Feet

78024571

Proper Diabetes management and foot care may help prevent complications that can result in amputation.

Diabetes complications include nerve damage and poor blood circulation. These problems make the feet vulnerable to skin sores (ulcers) that can worsen quickly and are difficult to treat.

The good news is that proper diabetes management and careful foot care can help prevent foot ulcers. In fact, better diabetes care is probably why the rates of lower limb amputations have gone down by more than 50 percent in the past 20 years.

When foot ulcers do develop, it’s important to get prompt care. A nonhealing ulcer that causes severe damage to tissues and bone may require surgical removal (amputation) of a toe, foot or part of a leg.

Here’s what you need to know to keep your feet healthy, and what happens if amputation is necessary.

Preventing Foot Ulcers

The best strategy for preventing complications of diabetes — including foot ulcers — is proper diabetes management with a healthy diet, regular exercise, blood sugar monitoring and adherence to a prescribed medication regimen.

Proper foot care will help prevent problems with your feet and ensure prompt medical care when problems occur. Tips for proper foot care include the following:

  • Inspect your feet daily. Check your feet once a day for blisters, cuts, cracks, sores, redness, tenderness or swelling. If you have trouble reaching your feet, use a hand mirror to see the bottoms of your feet. Place the mirror on the floor if it’s too difficult to hold, or ask someone to help you.
  • Wash your feet daily. Wash your feet in lukewarm water once a day. Dry them gently, especially between the toes. Use a pumice stone to gently rub the skin over where calluses easily form. Sprinkle talcum powder or cornstarch between your toes to keep the skin dry. Use a moisturizing cream or lotion on the tops and bottoms of your feet to keep the skin soft.
  • Don’t remove calluses or other foot lesions yourself. To avoid injury to your skin, don’t use a nail file, nail clipper or scissors on calluses, corns, bunions or warts. Don’t use chemical wart removers. See your doctor or foot specialist (podiatrist) for removal of any of these lesions.
  • Trim your toenails carefully. Trim your nails straight across. Carefully file sharp ends with an emery board. Ask for assistance from a caregiver if you are unable to trim your nails yourself.
  • Don’t go barefoot. To prevent injury to your feet, don’t go barefoot, even around the house.
  • Wear clean, dry socks. Wear socks made of fibers that pull sweat away from your skin, such as cotton and special acrylic fibers — not nylon. Avoid socks with tight elastic bands that reduce circulation, as well as thick bulky socks that often fit poorly and irritate your skin.
  • Buy shoes that fit properly. Buy comfortable shoes that provide support and cushioning for the heel, arch and ball of the foot. Avoid tightfitting shoes and high heels or narrow shoes that crowd your toes. If one foot is bigger than the other, buy shoes in the larger size. Your doctor may recommend specially designed shoes (orthopedic shoes) that fit the exact shape of your feet, cushion your feet and evenly distribute weight on your feet.
  • Don’t smoke. Smoking impairs circulation and reduces the amount of oxygen in the blood. These circulatory problems can result in more-severe wounds and poor healing. Talk to your doctor if you need help to quit smoking.
  • Schedule regular foot checkups. Your doctor or podiatrist can inspect your feet for early signs of nerve damage, poor circulation or other foot problems. Schedule foot exams at least once a year or more often if recommended by your doctor.
  • Take foot injuries seriously. Contact your doctor if you have a foot sore that doesn’t quickly begin to heal or other persistent problems with your feet. Your doctor will inspect your foot to make a diagnosis and prescribe the appropriate course of treatment.

What if Amputation is the Only Option?

Treatments for foot ulcers vary depending on the severity of the wound. In general, the treatment employs methods to remove dead tissue or debris, keep the wound clean, and promote healing. When the condition results in a severe loss of tissue or a life-threatening infection, an amputation may be the only option.

A surgeon will remove the damaged tissue and preserve as much healthy tissue as possible. After surgery, you’ll be monitored in the hospital for up to two weeks. It may take four to eight weeks for your wound to heal completely.

In addition to your primary care doctor and surgeon, other medical professionals involved in your treatment plan may include:

  • An endocrinologist, who is a physician with special training in the treatment of diabetes and other hormone-related disorders
  • A physical therapist, who will help you regain strength, balance and coordination and teach you how to use an artificial (prosthetic) limb, wheelchair or other devices to improve your mobility
  • An occupational therapist, who specializes in therapy to improve everyday skills, including teaching you how to use adaptive products to help with everyday activities
  • A mental health provider, such as a psychologist or psychiatrist, who can help you address your feelings or expectations related to the amputation or to cope with the reactions of other people
  • A social worker, who can assist with accessing services and planning for changes in care

Even after amputation, it’s important to follow your diabetes treatment plan. People who’ve had one amputation have a higher risk of having another. Eating healthy foods, exercising regularly, controlling your blood sugar level and avoiding tobacco can help you prevent additional diabetes complications.

Source: Mayo Clinic

Ruby A. Neeson Diabetes Awareness Foundation, Inc. is a Georgia-based nonprofit charitable organization heightening diabetes awareness and prevention through education, community outreach programs, and advocacy support.

We are dedicated and committed to creating supportable, sustainable opportunities for those affected by diabetes.

For information on services and organization opportunities, please visit www.fightdiabetesnow.org.

Fight Diabetes Now- Together We Can Win!

Make a Charitable Donation to Fight Diabetes in 2014

FINAL_COLOR_nobackground_withINC

We have less than 24 hours left before the arrival of 2015! This means there is still time for you to make a tax-deductible donation to Ruby A. Neeson Diabetes Awareness Foundation, Inc. before the New Year. Don’t miss this important deadline. Please make a donation now on the Donate page of the organization website.

No matter the amount – big or small – your contribution will make a profound difference in our mission to aid those affected by diabetes.

The mission of Ruby A. Neeson Diabetes Awareness Foundation, Inc. is to aid those affected by diabetes by raising public awareness through community outreach programs and events, education and advocacy programs and support.

Donations at work fund and support free educational workshops, cooking classes and nutrition programs, caregiver training and fitness classes for those disproportionately affected by diabetes in low-income and underserved communities throughout the state of Georgia.

On behalf of Ruby A. Neeson Diabetes Awareness Foundation, Inc. directors and staff, I sincerely thank you for your support.

Fight Diabetes Now- Together We Can Win!

Happy New Year!

Sincerely,

Mutima K. Jackson-Anderson, President & CEO

The Flu and Diabetes

200214561-001

Diabetes can weaken your immune system against the flu. It also puts you at an increased risk of flu-related complications.

  • Keep close track of your blood glucose. It can be affected by illness.
  • Get the flu vaccine. It is your best protection against the flu.
  • If you have diabetes you should get the flu shot, not the nasal spray.
  • If you have flu-like symptoms, contact your health care provider immediately.

Does Having Diabetes Put You at a Higher Risk for Getting the Flu?

Diabetes can weaken your immune system. This weakening makes it harder for your body to fight the flu virus. Being sick can raise your blood glucose and prevent you from eating properly.You are also at risk of flu-related complications like pneumonia.

Protect Yourself From Getting the Flu

Getting the flu vaccine is the most effective way to prevent the flu. The nasal spray vaccine is not safe for people with diabetes. You should get a flu shot.

Because you are at an increased risk of getting pneumonia, talk to your health care provider about the pneumococcal vaccine. The pneumococcal vaccine will protect you against pneumonia. In addition to getting vaccinated, follow these steps to keep yourself healthy this flu season.

What Should You Do When You Think You Have the Flu?

If you have any flu-like symptoms, contact your health care provider immediately. If you have the flu your health care provider can prescribe antiviral medications that can make your symptoms less severe and make you feel better faster.

In addition to following treatment recommendations, you should:

  • Continue taking your diabetes pills or insulin
  • Test your blood glucose every four hours and track your results
  • Drink lots of calorie-free liquids to stay hydrated
  • Try to eat as you would normally
  • Weigh yourself every day. Losing weight without trying is a sign of high blood glucose

Contact your health care provider or go to an emergency room immediately if you:

  • Are unable to eat normally
  • Go six hours without being able to keep food down
  • Have severe diarrhea
  • Lose five pounds or more
  • Have a temperature over 101o Fahrenheit
  • Get a blood glucose reading lower than 60 mg/dL or more than 300 mg/dL
  • Have trouble breathing
  • Feel sleepy or can’t think clearly

 

Source (s): www.flu.gov

For additional information from the CDC click here

Ruby A. Neeson Diabetes Awareness Foundation, Inc. is a Georgia-based community outreach organization raising diabetes awareness and prevention through education and advocacy support.

We are dedicated and committed to creating supportable, sustainable opportunities for those affected by diabetes.

For information on services and organization opportunities, please visit www.fightdiabetesnow.org.

Fight Diabetes Now- Together We Can Win!

World Diabetes Day, Healthy Living and Diabetes.

diabetes_logo

November 14 is World Diabetes Day.

This date coincides with the birthday of Sir Frederick Banting (b. November 14, 1891 – d. February 21, 1941).

Sir Frederick Banting was a Canadian medical scientist, doctor, painter and Nobel laureate noted as the primary discoverer of insulin with Charles Herbert Best. They were awarded the Nobel Prize in Physiology or Medicine in 1923.

banting-c1921-compressed

World Diabetes Day is the primary global awareness campaign of the diabetes mellitus world and is held on November 14 of each year. It was introduced in 1991 by the International Diabetes Federation and the World Health Organization in response to the alarming rise of diabetes around the world.

This year’s World Diabetes Day theme is, Healthy Living and Diabetes.

In recognition of World Diabetes Day, Ruby A. Neeson Diabetes Awareness Foundation, Inc. will host an event, “Taste of Health” at the Allegre Point Senior Community Center in Decatur, Georgia from 2:00 p.m until 4:00 p.m..

Taste of Health will focus on nutrition within the older adult community, and the importance of starting the day with a healthy breakfast, and preparing healthy, diabetic friendly snacks and meals for lunch and dinner.

Diabetes disproportionately affects older adults- senior citizens. Approximately 25% of Americans over the age of 60 years have diabetes, and aging of the U.S. population is widely acknowledged as one of the drivers of the diabetes epidemic. Diabetes also affects longevity, functional status, and risk of institutionalization for senior citizens.

Participants will receive diabetes nutrition and wellness education, and treated to a delicious lunch prepared by Chef Rolando “Ro” Cantrell.

Participants will also participate in a breakout session from Mavis Kelley of Nspire Healthy Living, a Health and Lifestyle Coaching organization enhancing health and well-being to expand wholeness in life.

November is also Diabetes Awareness Month.

The Centers for Disease Control and Prevention 2011 National Diabetes Fact Sheet informs that diabetes affects 25.8 million people 8.3% of the U.S. population. According to The American Diabetes Association, 57 million who are at risk of developing type two diabetes.

Ruby A. Neeson Diabetes Awareness Foundation, Inc. is dedicated and committed to creating supportable, sustainable opportunities for those affected by diabetes.

For more information about World Diabetes Day, please click here.

Fight Diabetes Now- Together We Can Win!

 

History of Diabetes

 

80407670

1910

English physiologist Sir Edward Albert Sharpey-Schafer’s study of the pancreas leads him to the discovery of a substance that would normally be produced in non-diabetics: insulin. The name comes from the Latin insula, meaning island, referencing the insulin-producing islets of Langerhans in the pancreas.

1916

Elliott Joslin, MD, publishes the first edition of The Treatment of Diabetes Mellitus. A clinician and educator, Joslin is renowned throughout the world as one of the most influential voices in diabetes care.

Fredrick_banting

1921

Frederick Banting, MD, and his then student assistant, Charles Best, MD, extract insulin from dog pancreases. Banting and Best were working in laboratory space at the University of Toronto provided by Professor J.J.R. Macleod. They inject the insulin into dogs whose pancreases have been removed, and the animals’ blood sugar levels go down. James Collip purifies the extract so that it can be used in humans. Banting and Macleod were awarded the 1923 Nobel Prize in Physiology or Medicine, though the contributions of all four men have been recognized as important in the discovery of insulin.

1923

Eli Lilly and Company begins commercial production of insulin. In the decades that follow, manufacturers develop a variety of slower-acting insulins, the first being protamine insulin introduced by Novo Nordisk in 1936.

1924

At a time when less than half of all babies born to mothers with diabetes survive, Priscilla White, MD, starts the Joslin Pregnancy Clinic. Fifty years later, Dr. White achieves a 90 percent survival rate among babies born to her patients.

1940

The American Diabetes Association is founded to address the increasing incidence of diabetes and the complications that develop from the disease.

1949

Rachmiel Levine, MD, discovers that insulin works like a key, transporting glucose into cells.

Becton Dickinson and Company begins production of a standardized insulin syringe designed and approved by the American Diabetes Association.

1950

The American Dietetic Association, and the U.S. Public Health Service devise a meal planner that divides foods into six groups, or “exchanges”, based on the calories, carbohydrateprotein, and fat in each serving of food.

1952

The American Diabetes Association funds its first direct research grants.

1953

Tablets for testing urine glucose become widely available, and urine test strips appear over the next few years. These options are simpler than using Benedict’s solution, which must be mixed with urine and heated over boiling water.

1955

Sulfonylureas, oral medications that stimulate the pancreas to release more insulin, are available. New, more potent forms of these drugs will become available later.

1959

Using radioimmunoassay technology, Solomon Berson, MD and Rosalyn Yalow, PhD develop a method for measuring insulin in the blood. They notice that some people with diabetes still make their own insulin, and they identify “insulin-dependent” (type 1) and “non-insulin-dependent” (type 2) diabetes.

1961

Glucagon, a hormone produced by the pancreas that raises glucose levels, is introduced by Eli Lilly and Company as a treatment for severe hypoglycemia.

1964

The Ames Company introduces the first strips for testing blood glucose by color code.

1966

The first successful pancreas transplant is performed at the University of Minnesota Hospital.

1970

The Ames Company introduces the first glucose meter.

1971

Insulin receptors are discovered on cell membranes. This discovery raises the possibility that missing or defective insulin receptors may prevent glucose from entering the cells, thus contributing to the insulin resistance of type 2 diabetes.

1972

The relationship between blood vessel disease and hyperglycemia is reported.

U100 insulin is introduced. With the availability of this single concentration and with insulin syringes marked with only a U100 scale, frequency of dosing errors could be reduced.

1974

Development of the Biostator enabled continuous glucose monitoring and closed loop insulin infusion.

Human Leukocyte Antigens (HLAs) are discovered on cell surfaces. People with type 1 diabetes have specific patterns of HLA that are associated with varying levels of risk for diabetes.

first portable insulin infusion pump

1976

The first insulin pumps were invented.

1977

Rosalyn Yalow, PhD is awarded the Nobel Prize in Physiology and Medicine for her work in measuring insulin in the body.

Boston researchers develop a test to measure glycosylated hemoglobin (A1C). A1C testing becomes the gold standard for measuring long-term diabetes control.

1978

Researchers at the City of Hope National Medical Center in Duarte, California, and Genentech, Inc., in San Francisco, induce E. coli bacteria to produce insulin identical to human insulin.

Portable insulin pumps are introduced and researchers achieve normal blood glucose levels in patients using them. But, due to their large size, they are impractical at this time.

The National Diabetes Information Clearinghouse is created by the federal government to gather and document all diabetes literature.

1979

The National Diabetes Data Group develops a new diabetes classification system: 1) insulin-dependent or type 1 diabetes, 2) non-insulin-dependent or type 2 diabetes, 3) gestational diabetes, and 4) diabetes associated with other syndromes or conditions.

1980

A new animal model of type 1 diabetes, the non-obese diabetic (NOD) strain of mouse is described in Japan.

Introduction of the basal-bolus concept enabled “intensive insulin therapy” to be used in the clinic to effectively treat people with type 1 diabetes.

1982

The FDA approves human insulin produced by genetically altered bacteria.

A 64K autoantibody is discovered and is found to be associated with type 1 diabetes.

1983

A link between hypoglycemia and brain metabolism is established.

Second-generation sulfonylureas enter the market allowing patients to take smaller doses and with reduced side effects.

1984

The insulin molecule is identified to be a target of autoimmune response in individuals with type 1 diabetes.

1985

Scientists discover a relationship between pregnancy and the worsening of diabetic retinopathy.

1986

The National Diabetes Data Group reports that type 2 diabetes is more common among African Americans, Mexican Americans, and Native Americans than among Caucasians. Fifty percent of all Pima Indians in Arizona over the age of 35 have diabetes – the highest rate in the world.

1987

The 64K autoantibody originally discovered in 1982 is found to be predictive of type 1 diabetes.

Researchers determine that tight control of glucose levels during pregnancy is important for the health of the baby, and continue to study how diabetes increases the risk for birth defects.

1989

American Diabetes Association releases its first Standards of Care to guide physicians in the treatment of diabetes.

Glucose is discovered to be distributed into muscle and fat cells via a transporter known as GLUT-4. Understanding how glucose is transported from the bloodstream into cells to be used as fuel is important to locating different drug targets that can improve insulin sensitivity.

1990

The 64K autoantibody associated with type 1 diabetes is identified. This protein, GAD, or glutamate decarboxylase, is an important enzyme involved in cellular communication in the brain and pancreas. The immune system’s attack on GAD triggers a progressive autoimmune response that leads to diabetes.

1993

The Diabetes Control and Complications Trial (DCCT) showed that keeping blood glucose levels as close to normal as possible slows the onset and progression of eye, kidney, and nerve diseases caused by diabetes. In fact, it demonstrated that any sustained lowering of blood glucose helps, even if the person has a history of poor control.

1994

Captopril is FDA approved to treat end-stage renal disease.

Leptin, the fat cell hormone that modulates feeding behavior and hormone secretion, is cloned.

The Scandinavian Simvistatin Survival Study (4S) showed that cholesterol lowering with statins markedly reduced the risk of myocardial infarctionstroke or death. The effect was greatest in individuals with diabetes.

Mid-1990’s

The incretin hormone GLP-1 is discovered. Incretin hormones are secreted from the gut in response to food, and encourage the body to produce insulin. Discovery of GLP-1 will later lead to a new class of diabetes drugs that can increase insulin secretion in response to glucose, and even increase the amount of beta cells in the pancreas.

1995

The drug metformin becomes available in the U.S. Metformin is a biguanide that prevents glucose production in the liver.

1996

The drug acarbose, brand name Precose (Bayer Corporation) becomes available in the U.S. Acarbose is an alpha-glucosidase inhibitor that slows digestion of some carbohydrates.

Lispro (a lysine-proline analog) is introduced by Eli Lilly and Company as the world’s fastest acting insulin.

1997

Troglitazone, brand name Rezulin (Parke-Davis), is approved by the FDA. It is the first in a class of drugs known as thiazolidinediones, and it improves insulin sensitivity in muscle cells. It is eventually removed from the market due to liver toxicity. Rosiglitazone and pioglitazone, also in this drug class, are later brought on to the market.

The terms “insulin-dependent diabetes” (IDDM) and “non-insulin-dependent diabetes” (NIDDM) had long been used to describe different groups of diabetes patients. The terms type 1 diabetes and type 2 diabetes are now accepted to define diabetes by cause rather than treatment. In addition, the fasting glucose level for diagnosing diabetes is lowered from 140 mg/dl to 126 mg/dl.

1998

Repaglinide, brand name Prandin (Novo Nordisk) is developed. Repaglinide belongs to a class of drugs known as meglitinides. They stimulate insulin secretion in the presence of glucose.

The United Kingdom Prospective Diabetes Study (UKPDS) shows that people with type 2 diabetes who practice tight control of blood sugar levels and blood pressure levels reduce their risk of complications, similar to the results of the DCCT in people with type 1 diabetes. Together these two studies transform the nature of diabetes care around the world.

2002

Treatment with the anti-CD3 monoclonal antibody, hOKT3gamma1(Ala-Ala), slows the deterioration of insulin production and improves metabolic control during the first year of type 1 diabetes in the majority of patients.

The American Diabetes Association defines prediabetes as impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT). IFG is defined as a fasting blood glucose of 100-125 mg/dl, and IGT is defined as a glucose level from 140 mg/dl – 199 mg/dl two hours after consuming a glucose-rich drink. Later, A1C levels of 5.7% to 6.4% are also used to identify individuals with prediabetes.

2005

Exenatide, brand name Byetta, is approved in the U.S. as a first-in-class incretin mimetic (GLP-1) drug to treat type 2 diabetes. An injectable drug, exenatide works by increasing insulin production in response to blood glucose levels.

Pramlintide, brand name Symlin, is approved in the U.S. as an injectable adjunct treatment for people who use insulin at mealtimes but still fail to achieve desirable blood glucose levels.

2006

FDA approves JANUVIA (sitagliptin phosphate), the first in a new class of drugs known as DPP-4 inhibitors that enhance the body’s ability to lower elevated blood sugar. DPP-4 is an enzyme that naturally blocks GLP-1 from working, so by inhibiting this enzyme, GLP-1 works in the gut to promote insulin secretion.

2008

The results of the ACCORD, ADVANCE and VADT studies are published and presented at the American Diabetes Association Scientific Sessions. All three studies fail to show a benefit of intensive glycemic control on cardiovascular outcomes in people with type 2 diabetes who are at high cardiovascular risk. The results from these studies lead to clinical recommendations that call for a more individualized approach for setting glycemic goals and treatment targets.

2013

FDA approves Invokana (Canagliflozin), the first in a new class of drugs know as the SGLT-2 inhibitors, for lowering elevated blood sugar in patients with type 2 diabetes. SGLT-2 inhibitors block the activity of sodium glucose transport proteins in the kidney, reducing glucose re-uptake and increasing secretion of glucose in the urine.

 

Source (s): American Diabetes Association

Ruby A. Neeson Diabetes Awareness Foundation, Inc. is a Georgia-based community outreach organization raising diabetes awareness and prevention through education and advocacy support.

We are dedicated and committed to creating supportable, sustainable opportunities for those affected by diabetes.

For information on services and organization opportunities, please visit www.fightdiabetesnow.org.

Health Effects of Childhood Obesity

57281237

Childhood obesity has both immediate and long-term effects on health and well-being.

Immediate health effects:

  • Obese youth are more likely to have risk factors for cardiovascular disease, such as high cholesterol or high blood pressure. In a population-based sample of 5- to 17-year-olds, 70% of obese youth had at least one risk factor for cardiovascular disease.
  • Obese adolescents are more likely to have prediabetes, a condition in which blood glucose levels indicate a high risk for development of diabetes.
  • Children and adolescents who are obese are at greater risk for bone and joint problems, sleep apnea, and social and psychological problems such as stigmatization and poor self-esteem.

Long-term health effects:

  • Children and adolescents who are obese are likely to be obese as adults and are therefore more at risk for adult health problems such as heart disease, type 2 diabetes, stroke, several types of cancer, and osteoarthritis.  One study showed that children who became obese as early as age 2 were more likely to be obese as adults.
  • Overweight and obesity are associated with increased risk for many types of cancer, including cancer of the breast, colon, endometrium, esophagus, kidney, pancreas, gall bladder, thyroid, ovary, cervix, and prostate, as well as multiple myeloma and Hodgkin’s lymphoma
Childhood Obesity Prevention
  • Healthy lifestyle habits, including healthy eating and physical activity, can lower the risk of becoming obese and developing related diseases.
  • The dietary and physical activity behaviors of children and adolescents are influenced by many sectors of society, including families, communities, schools, child care settings, medical care providers, faith-based institutions, government agencies, the media, and the food and beverage industries and entertainment industries.
  • Schools play a particularly critical role by establishing a safe and supportive environment with policies and practices that support healthy behaviors. Schools also provide opportunities for students to learn about and practice healthy eating and physical activity behaviors.
Childhood Obesity Resources:

Source (s): Centers for Disease Control and Prevention

Ruby A. Neeson Diabetes Awareness Foundation, Inc. is a Georgia-based community outreach organization raising diabetes awareness and prevention through education and advocacy support. For information on services and organization opportunities, please visit www.fightdiabetesnow.org.

Fight Diabetes Now- Together We Can Win!